← All diseases Liver, kidneys and digestion

Liver cirrhosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest Quality Evidence Only (112)Meta-analysis (33)Treatment guideline (8)Randomized trial (33)Systematic review (22)Phase 3 study (16)Clinical trial (636)Review article (465)Early study (phase 1 or 2) (8)Laboratory or animal research (168)Case report (153)Commentary or editorial (44)Retracted Publication (4) Studies Currently Seeking Participants Only (38)

Filter

Publications and studies (3132)

• The moderating effect of dietary fiber intake on the association between sleep pattern and liver fibrosis in metabolic dysfunction-associated steatotic liver disease: a study from NHANES. (2024/12/18) ♡
• Association between bowel movement frequency, stool consistency and MAFLD and advanced fibrosis in US adults: a cross-sectional study of NHANES 2005-2010. (2024/12/18) ♡
• The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease. (2024/12/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Hepatocellular carcinoma (HCC)]. (2024/12/18) ♡
• Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis. (2024/12/18) ♡
• Wanted: Dead or Alive Cells with Propidium Iodide Staining in Liver Tissue. (2024/12/17) ♡
• Expression of miR-15b-5p and toll-like receptor4 as potential novel diagnostic biomarkers for hepatitis C virus-induced hepatocellular carcinoma. (2024/12/15) ♡
• Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts. (2024/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fanlian Huazhuo Formula: A promising herbal preparation for metabolic liver disease. (2024/12/14) ♡
• Risk factors for postoperative morbidity after ventral hernia repair in patients with liver cirrhosis. A single tertiary center cohort. (2024/12/13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Emerging role of natural bioactive compounds in navigating the future of liver disease. (2024/12/13) ♡
• Identification of key factors for malnutrition diagnosis in chronic gastrointestinal diseases using machine learning underscores the importance of GLIM criteria as well as additional parameters. (2024/12/12) ♡
• Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations. (2024/12/12) ♡
• The Midlands Liver Research Alliance - A partnership to optimise obesity-related liver disease research: targeting areas of high incidence and underserved communities. (2024/12/12) ♡
• Quantitative fibrosis identifies biliary tract involvement and is associated with outcomes in pediatric autoimmune liver disease. (2024/12/11) ♡
• Caffeine supplement, inflammation, and hepatic function in cirrhotic patients: A randomized, placebo-controlled, clinical trial. (2024/12/11) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Non-invasive assessment of portal hypertension: Liver stiffness and beyond. (2024/12/11) ♡
• Transaneurysmal Suturing of Pseudoaneurysm Neck: Novel and Not a Pseudo-Technique for Treatment of Complicated Femoral Pseudoaneurysm. (2024/12/11) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease. (2024/12/10) ♡
• Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome. (2024/12/10) ♡
• Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death. (2024/12/06) ♡
• Experimental study on H(2)O(2) activation of HSC-T6 and hepatic fibrosis in cholestatic mice by "Yajieshaba". (2024/12/05) ♡
• An 8-Week Very Low-Calorie Ketogenic Diet (VLCKD) Alters the Landscape of Obese-Derived Small Extracellular Vesicles (sEVs), Redefining Hepatic Cell Phenotypes. (2024/12/04) ♡
• Molecular MRI of T-cell immune response to cryoablation in immunologically hot vs. cold hepatocellular carcinoma. (2024/12/04) ♡
• Hypoalbuminemia is Associated with Higher 90-Day Mortality and Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma and Liver Cirrhosis Receiving Radiotherapy-Based Therapy. (2024/12/03) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Canal of Nuck hydrocele in elderly female with cirrhosis: A case report and review of literature. (2024/12/01) ♡
• Dahuang Zhechong Pill Alleviates Liver Fibrosis Progression by Regulating p38 MAPK/NF-κ B/TGF-β1 Pathway. (2024/12/01) ♡
• The processing mechanism of vinegar-processed Curcumae Rhizome enhances anti hepatic fibrotic effects through regulation of PI3K/Akt/mTOR signaling pathway. (2024/12/01) ♡
• Mechanism Research of QingReJieDu Formula for Treating Hepatitis B Virus Based on Network Pharmacology. (2024/12/01) ♡
• Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study. (2024/12/01) ♡
• Mitochondrial DNA Depletion Syndromes Gene Panel versus Clinical Exome Sequencing in Children with Suspected Mitochondrial Hepatopathies. (2024/12/01) ♡
• Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. (2024/12/01) ♡
• Association of liver fibrosis scores with all-cause and cardiovascular mortality in patients with heart failure. (2024/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unravelling the coagulation paradox in liver cirrhosis: challenges and insights. (2024/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MASH to cirrhosis: bridging the gaps in MASLD management. (2024/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the surgical technique of Kasai portoenterostomy. (2024/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Bubbles in the Heart: A Case Series of Three Varying Presentations of Hepatopulmonary Syndrome. (2024/12/01) ♡
• Recent updates on molecular epidemiology of hepatitis C virus in Gujranwala, Pakistan. (2024/12/01) ♡
• Shared genetic architecture of non-viral cirrhosis with several pleiotropic traits: A nested case-control study in the UK Biobank. (2024/12/01) ♡
• Telemedicine in the tertiary liver unit: A feasibility study. (2024/12/01) ♡
• [Evaluation of the efficacy and safety profile of tenofovir amibufenamide at 48 weeks during the treatment of hepatitis B virus-related cirrhosis]. (2024/11/30) ♡
• [Real-world study of tenofovir amibufenamide in the treatment of patients with hepatitis B cirrhosis]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of hepatitis B cirrhosis combined with streptococcal spondylitis and secondary pan-drug-resistant bacterial infection]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Tenofovir amibufenamide treatment in a case of hepatitis B virus-related decompensated liver cirrhosis]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Tenofovir amibufenamide inhibiting low-level viremia and delaying the progression of liver cirrhosis: a case report]. (2024/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of decompensated hepatitis B virus-related cirrhosis combined with renal injury rescue treatment using tenofovir amibufenamide tablet]. (2024/11/30) ♡
• Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht Study. (2024/11/29) ♡
• Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese mice. (2024/11/29) ♡
• Novel Choline-Deficient and 0.1%-Methionine-Added High-Fat Diet Induces Burned-Out Metabolic-Dysfunction-Associated Steatohepatitis with Inflammation by Rapid Immune Cell Infiltration on Male Mice. (2024/11/29) ♡
• Association of liver biopsy pathology on outcome of patients undergoing heart transplantation. (2024/11/29) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.